Postpartum Prescription of GLP-1 Drugs Has Increased Sharply, Study Finds
By mid-2024, the weight-loss drugs were prescribed for almost 2 percent of new mothers.
Wegovy being packaged at a Novo Nordisk facility in Hillerod, Denmark.

© Tom Little/Reuters